Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Comment: Pregnancy outcomes in patients with chronic myeloid leukaemia

Prof Anton Hagenbeek - University of Amsterdam, Amsterdam, The Netherlands

Comment: Pregnancy outcomes in patients with chronic myeloid leukaemia ( Prof Anton Hagenbeek - University of Amsterdam, Amsterdam, The Netherlands )

Comment: Fixed-duration venetoclax plus obinutuzumab in patients with CLL and...

Prof Anton Hagenbeek - University of Amsterdam, Amsterdam, The Netherlands

Comment: Fixed-duration venetoclax plus obinutuzumab in patients with CLL and comorbidities ( Prof Anton Hagenbeek - University of Amsterdam, Amsterdam, The Netherlands )

AlloHCT conditioning intensity in AML in complete remission with residual...

Dr Christopher Hourigan - National Heart, Lung, and Blood Institute, Bethesda...

AlloHCT conditioning intensity in AML in complete remission with residual disease ( Dr Christopher Hourigan - National Heart, Lung, and Blood Institute, Bethesda, USA )

ASCEND: Acalabrutinib versus rituximab with idelalisib or bendamustine in...

Prof Paolo Ghia - Vita-Salute San Raffaele University, Milan, Italy

$ASCEND: Acalabrutinib versus rituximab with idelalisib or bendamustine in relapsed or refractory CLL ( Prof Paolo Ghia - Vita-Salute San Raffaele University, Milan, Italy )$

Inhibition of NADK strongly inhibits T-ALL cells from growing

Dr Etienne De Braekeleer - Wellcome Sanger Institute, Cambridge, UK

Inhibition of NADK strongly inhibits T-ALL cells from growing ( Dr Etienne De Braekeleer - Wellcome Sanger Institute, Cambridge, UK )

Novel immunotherapy 5F9 plus rituximab well tolerated with rapid and durable...

Dr Mark Roschewski - National Cancer Institute, Bethesda, USA

Novel immunotherapy 5F9 plus rituximab well tolerated with rapid and durable responses in R/R DLBCL and indolent lymphoma ( Dr Mark Roschewski - National Cancer Institute, Bethesda, USA )

Venetoclax with bortezomib and dexamethasone shows good response but higher...

Dr Shaji Kumar - Mayo Clinic, Rochester, USA

Venetoclax with bortezomib and dexamethasone shows good response but higher risk of treatment related death in RRMM ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )

Acalabrutinib monotherapy shows significant benefit in relapsed or refractory...

Dr Paolo Ghia - Vita-Salute San Raffaele University, Milan, Italy

$Acalabrutinib monotherapy shows significant benefit in relapsed or refractory chronic lymphocytic leukaemia ( Dr Paolo Ghia - Vita-Salute San Raffaele University, Milan, Italy )$

Imetelstat provides durable transfusion independence in heavily transfused non...

Dr Pierre Fenaux - Hôpital St Louis and Paris University, Paris, France

Imetelstat provides durable transfusion independence in heavily transfused non-del(5q) LR-MDS R/R to ESAS ( Dr Pierre Fenaux - Hôpital St Louis and Paris University, Paris, France )

D-VTd in induction prior to and consolidation after ASCT improves PFS and depth...

Prof Philippe Moreau - Chu Nantes, Nantes, France

D-VTd in induction prior to and consolidation after ASCT improves PFS and depth of response with acceptable safety ( Prof Philippe Moreau - Chu Nantes, Nantes, France )

Venetoclax plus obinutuzumab improves PFS and MRD-negativity in patients with...

Dr Kirsten Fischer - Uniklinik Köln, Cologne, Germany

Venetoclax plus obinutuzumab improves PFS and MRD-negativity in patients with previously untreated CLL and comorbidities ( Dr Kirsten Fischer - Uniklinik Köln, Cologne, Germany )

Most pregnancies in CML patients resulted in normal childbirth: Analysis of 305...

Dr Ekaterina Chelysheva - National Research Center for Hematology, Moscow...

Most pregnancies in CML patients resulted in normal childbirth: Analysis of 305 cases of the European Leukemia Net registry ( Dr Ekaterina Chelysheva - National Research Center for Hematology, Moscow, Russian Federation )

More from ecancer